Literature DB >> 8097581

Mutational analysis of the role of the carboxy-terminal region of the v-erbB protein in erythroid cell transformation.

E B Lee1, H Beug, M J Hayman.   

Abstract

The v-erbB protein encoded by the avian erythroblastosis virus AEV-H is responsible for the transformation of fibroblasts and erythroblasts by this virus. Deletion of amino acids 961-1102, which lie carboxy terminal to the kinase domain of the v-erbB protein, destroys the ability of the virus to transform erythroid cells without severely affecting fibroblast transformation. This region is termed the E-domain and has been postulated to contain a region important for erythroid cell transformation. In-frame deletions of approximately 23 amino acids were introduced throughout the E-domain in an attempt to locate a specific region that was essential for erythroid cell transformation. Several of the deletions gave rise to a partial transformed phenotype, although no single deletion that completely abolished erythroid cell transformation was found. Interestingly, deletion of amino acids 1031-1055 resulted in a superactivated v-erbB protein that was more active for erythroid cell transformation than the wild-type AEV-H v-erbB protein. This indicates that there is a negative regulatory region located within this region that normally partially suppresses the transforming activity of the v-erbB protein for erythroid cells. These data suggest that the E-domain contains both negative and positive regulatory regions that function in erythroid cells, and complete deletion of the region is necessary to abolish erythroid cell transformation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097581

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer.

Authors:  Aldema Sas-Chen; Roi Avraham; Yosef Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-12       Impact factor: 2.673

2.  Modulation of erbB kinase activity and oncogenic potential by single point mutations in the glycine loop of the catalytic domain.

Authors:  H K Shu; C M Chang; L Ravi; L Ling; C M Castellano; E Walter; R J Pelley; H J Kung
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

3.  A minor tyrosine phosphorylation site located within the CAIN domain plays a critical role in regulating tissue-specific transformation by erbB kinase.

Authors:  C M Chang; H K Shu; L Ravi; R J Pelley; H Shu; H J Kung
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  Disease specificity of kinase domains: the src-encoded catalytic domain converts erbB into a sarcoma oncogene.

Authors:  C M Chang; H K Shu; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

5.  FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement.

Authors:  M V Lorenzi; Y Horii; R Yamanaka; K Sakaguchi; T Miki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

6.  Analysis of the role of the Shc and Grb2 proteins in signal transduction by the v-ErbB protein.

Authors:  S Meyer; K LaBudda; J McGlade; M J Hayman
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.